Skip to main content
. 2015 Oct 16;4(1):107–113. doi: 10.3892/mco.2015.658

Figure 3.

Figure 3.

ASCT and MT affected PFS but not OS in the patients achieving a very good partial response prior to ASCT. (A) The median PFS ± standard deviation of the four arms (ASCT/MT, ASCT/non-MT, non-ASCT/MT, non-ASCT/non-MT) was NR (not reached), 32±5.667, 25±3.742, 15±3.637, respectively. (B) The 3-year OS rate of the four arms was 80, 75, 83 and 60%, respectively. PFS, progression-free survival; OS, overall survival; ASCT, autologous hematopoietic stem cell transplantation; MT, maintenance therapy.